Clinical Trial

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Name: Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers — clinical trial record (NCT06690177)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: VLU

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The main objective of this study is: To assess the safety of EscharEx (EX-03 5% formulation) compared to placebo control and compared to Collagenase (NSSOC) in patients with VLU.

Trial Details

NCT Number	NCT06690177
Lead Sponsor	MediWound Ltd
Conditions	Venus Leg Ulcers
Enrollment	45 participants
Start Date	2025-04-30
Primary Completion	2027-12-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-11-15